Neutrophil Migration Assay with Zebrafish: A Preclinical Perspective

In Drug Discovery and Development, the evaluation of compound immunotoxicity is a critical component. Zebrafish has surfaced as a valuable model organism for immunotoxicity studies, with the Neutrophil Migration Assay providing a robust and effective method for these evaluations. 

Zebrafish in the Study of Angiogenesis Inhibition

Angiogenesis is a dynamic process by which new blood vessels form from pre-existing vasculature. This process begins with vasculogenesis, the de novo formation of vessels, which then go through further alteration and expansion through angiogenesis. Unlike most other tissues, vasculature exhibits a outstanding regenerative capacity, enabling it to grow and repair damaged tissues even in adult organisms.

Driving Drug Discovery Forward: Strategic Lead Optimization

Drug Discovery and Development is a complex, multi-phase process aimed at ensuring the safety and efficacy of new therapeutic compounds before they reach the market. This article provides a broad overview of the journey from initial discovery to market approval, with a special focus on the pivotal phase of Lead Optimization.

Navigating OECD Guidelines for Chronic Toxicity Studies

Chronic toxicity studies are specialized assays designed to evaluate the potential adverse health effects resulting from repeated or continuous exposure to a substance over an extended period. These studies aim to characterize the long-term impact of such exposure on biological systems. 

Understanding the Updated EU CLP Classes: Enhancing Chemical Safety in Europe

The European Chemicals Agency (ECHA) has introduced significant updates to the European Union (EU) CLP (Classification, Labelling, and Packaging) regulation, strengthening its framework for classifying and managing chemical hazards. These updates reflect scientific advancements and aim to protect human health and the environment from potential chemical risks.